UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation

American journal of neuroradiology : AJNR, 2015-07, Vol.36 (7), p.1237-1244

2015

Volltextzugriff (PDF)

SDHB mutation carriers with malignant pheochromocytoma respond better to CVD

Endocrine-related cancer, 2017-08, Vol.24 (8), p.L51-L55

2017

Volltextzugriff (PDF)

Evaluating the impact of new imaging tests: promises and pitfalls

JNCI : Journal of the National Cancer Institute, 2012-12, Vol.104 (24), p.1857-1859

2012

Volltextzugriff (PDF)

Abstract PD4-07: PET imaging of PARP-1 expression in breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD4-07-PD4-07

2019

Volltextzugriff (PDF)

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124 I-cG250) and PET in patients with renal masses: a phase I trial

The lancet oncology, 2007-04, Vol.8 (4), p.304-310

2007

Volltextzugriff (PDF)

Phase II/pharmacodynamic trial of PD0332991 in patients with breast, colon, germ cell, and epithelial tumors containing amplification of CCND1

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3088-3088

2011

Volltextzugriff (PDF)

Preliminary data from an ongoing phase IIb study of no carrier added 131 I-iobenguane (nca-MIBG) in patients with malignant pheochromocytoma (Pheo)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21122-e21122

2011

Volltextzugriff (PDF)

Development of Companion Diagnostics

Seminars in nuclear medicine, 2016, Vol.46 (1), p.47-56

2016

Volltextzugriff (PDF)

Hydronephrotic Ectopic Pelvic Kidney Simulates Sacral Metastasis From Breast Cancer

Clinical nuclear medicine, 2005-04, Vol.30 (4), p.244-245

2005

Volltextzugriff (PDF)

Parathyroid Imaging

Neuroimaging clinics of North America, 2008-08, Vol.18 (3), p.537-549

2008

Volltextzugriff (PDF)

Cardiovascular risk assessment in cancer patients undergoing major surgery

Journal of nuclear cardiology, 2005-03, Vol.12 (2), p.151-157

2005

Volltextzugriff (PDF)

Acute intramural hematoma of the aorta as a cause of positive fluorodeoxyglucose positron emission tomography/computed tomography

The Journal of thoracic and cardiovascular surgery, 2007-08, Vol.134 (2), p.520-521

2007

Volltextzugriff (PDF)

PET/CT imaging in cancer: Current applications and future directions

Cancer, 2014-11, Vol.120 (22), p.3433-3445

2014

Volltextzugriff (PDF)

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

Nature (London), 2015-04, Vol.520 (7547), p.373-377

2015

Volltextzugriff (PDF)

A PET imaging agent for evaluating PARP-1 expression in ovarian cancer

The Journal of clinical investigation, 2018-05, Vol.128 (5), p.2116-2126

2018

Volltextzugriff (PDF)

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

Pancreas, 2021-04, Vol.50 (4), p.469

2021

Volltextzugriff (PDF)

A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy

Cancer research (Chicago, Ill.), 2016-08, Vol.76 (15), p.4516-4524

2016

Volltextzugriff (PDF)

2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2018-06, Vol.71 (24), p.e283-e351

2018

Volltextzugriff (PDF)

Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models

Molecular cancer therapeutics, 2019-07, Vol.18 (7), p.1195-1204

2019

Volltextzugriff (PDF)

Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review

JAMA oncology, 2017-05, Vol.3 (5), p.695

2017

Volltextzugriff (PDF)

A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document

International journal of radiation oncology, biology, physics, 2021-03, Vol.109 (4), p.913-922

2021

Volltextzugriff (PDF)

In vivo visualization of PARP inhibitor pharmacodynamics

JCI insight, 2021-04, Vol.6 (8)

2021

Volltextzugriff (PDF)

The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer

Biochemical and biophysical research communications, 2015-11, Vol.467 (4), p.1070-1075

2015

Volltextzugriff (PDF)

A Phase II Study of Nelfinavir plus Concurrent Chemoradiation for Advanced, HPV-Negative Squamous Cell Carcinoma of the Head and Neck

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S144

2022

Volltextzugriff (PDF)

Prospective Study of Systemic Yttrium-90 Elution during Radioembolization of Hepatic Metastases

Journal of vascular and interventional radiology, 2020-12, Vol.31 (12), p.2007-2013.e1

2020

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Humans
(33)
Life Sciences & Biomedicine
(32)
Female
(16)
Oncology
(14)
Positron Emission Tomography
(11)
Radiology
(11)
Radiology, Nuclear Medicine & Medical Imaging
(11)
Acc Expert Consensus Document
(10)
Aged
(10)
Nuclear Cardiology
(10)
Radiation Risk
(10)
Radiation Safety
(10)
Middle Aged
(9)
Patients
(9)
Single-Photon Computed Tomography
(9)
X-Ray Computed Tomography
(9)
X-Ray Fluoroscopy
(9)
Adult
(8)
Male
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation

SDHB mutation carriers with malignant pheochromocytoma respond better to CVD

Evaluating the impact of new imaging tests: promises and pitfalls

Abstract PD4-07: PET imaging of PARP-1 expression in breast cancer

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124 I-cG250) and PET in patients with renal masses: a phase I trial

Phase II/pharmacodynamic trial of PD0332991 in patients with breast, colon, germ cell, and epithelial tumors containing amplification of CCND1

Preliminary data from an ongoing phase IIb study of no carrier added 131 I-iobenguane (nca-MIBG) in patients with malignant pheochromocytoma (Pheo)

Development of Companion Diagnostics

Hydronephrotic Ectopic Pelvic Kidney Simulates Sacral Metastasis From Breast Cancer

Parathyroid Imaging

Cardiovascular risk assessment in cancer patients undergoing major surgery

Acute intramural hematoma of the aorta as a cause of positive fluorodeoxyglucose positron emission tomography/computed tomography

PET/CT imaging in cancer: Current applications and future directions

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

A PET imaging agent for evaluating PARP-1 expression in ovarian cancer

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy

2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models

Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review

A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document

In vivo visualization of PARP inhibitor pharmacodynamics

The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer

A Phase II Study of Nelfinavir plus Concurrent Chemoradiation for Advanced, HPV-Negative Squamous Cell Carcinoma of the Head and Neck

Prospective Study of Systemic Yttrium-90 Elution during Radioembolization of Hepatic Metastases

Suchergebnisse filtern